Amid the growth of addiction medicine randomized controlled trials (RCTs), scholars have begun examining participants’ study experiences, highlighting facilitators and barriers to enrollment. However, this work can overlook the interplay between trial participation and social-structural dimensions among people with substance use disorders linked to the social nature of use, socioeconomic marginalization, and time demands of substance procurement and use. To effectively conduct RCTs with this unique population, it is necessary to examine the broader social context of study participation. We conducted nested qualitative interviews with 22 participants involved in an RCT testing a treatment for alcohol and opioid use disorders in HIV clinics. Thematic analyses revealed social-structural circumstances shaping RCT participation as well as how participation constitutes a turning point, prompting individuals to reconfigure social networks, reorient to spatial environments, and reorganize day-to-day life—with implications for how substance use disorder RCTs should be approached by researchers.
BothwellL. E.GreeneJ. A.PodolskyS. H.JonesD. S. (2016). Assessing the gold standard—Lessons from the history of RCTs. New England Journal of Medicine, 374(22), 2175–2181.
BrookfieldS.FitzgeraldL.SelveyL.MaherL. (2019). Turning points, identity, and social capital: A meta-ethnography of methamphetamine recovery. International Journal of Drug Policy, 67, 79–90. https://doi.org/10.1016/j.drugpo.2019.02.002
4.
CaldwellP. H. Y.HamiltonS.TanA.CraigJ. C. (2010). Strategies for increasing recruitment to randomised controlled trials: Systematic review. PLOS Medicine, 7(11), e1000368. https://doi.org/10.1371/journal.pmed.1000368
5.
CampbellL.BoydN.CulbertL. (2009). A thousand dreams. Greystone Books.
6.
CharmazK. (2014). Constructing grounded theory (2nd ed.). SAGE.
7.
ChenD. T.KoT. M.AllenA. A.BonnieR. J.SurattC. E.AppelbaumP. S.O’BrienC. P. (2018). Personal control over decisions to participate in research by persons with histories of both substance use disorders and criminal justice supervision. Journal of Empirical Research on Human Research Ethics, 13(2), 160–172. https://doi.org/10.1177/1556264618755243
8.
CooperS.CampbellG.LaranceB.MurnionB.NielsenS. (2018). Perceived stigma and social support in treatment for pharmaceutical opioid dependence. Drug and Alcohol Review, 37(2), 262–272. https://doi.org/10.1111/dar.12601
9.
CreswellJ. W.Plano ClarkV. L. (2017). Designing and conducting mixed methods research. SAGE.
10.
DrausP.RoddyJ.AsabigiK. (2015). Making sense of the transition from the Detroit streets to drug treatment. Qualitative Health Research, 25(2), 228–240. https://doi.org/10.1177/1049732314552454
11.
EarnshawV. A.SmithL. R.CunninghamC. O.CopenhaverM. M. (2015). Intersectionality of internalized HIV stigma and internalized substance use stigma: Implications for depressive symptoms. Journal of Health Psychology, 20(8), 1083–1089. https://doi.org/10.1177/1359105313507964
12.
ElderG. H.JohnsonM. K.CrosnoeR. (2003). The emergence and development of life course theory. In MortimerJ. T.ShanahanM. J. (Eds.), Handbook of the life course (pp. 24–0). Kluwer Academic/Plenum Publishers.
13.
FastD.SmallW.KrüsiA.WoodE.KerrT. (2010). “I guess my own fancy screwed me over”: Transitions in drug use and the context of choice among young people entrenched in an open drug scene. BMC Public Health, 10, 126. https://doi.org/10.1186/1471-2458-10-126
14.
GaleaS.VlahovD. (2002). Social determinants and the health of drug users: Socioeconomic status, homelessness, and incarceration. Public Health Reports, 117(Suppl. 1), S135–S145.
15.
GoodmanA.MorganR.KuehlkeR.KastorS.FlemingK.BoydJ. (2018). “We’ve been researched to death”: Exploring the research experiences of urban Indigenous Peoples in Vancouver, Canada. International Indigenous Policy Journal, 9(2). https://doi.org/10.18584/iipj.2018.9.2.3
16.
GranfieldR.CloudW. (2001). Social context and “natural recovery”: The role of social capital in the resolution of drug-associated problems. Substance Use and Misuse, 36(11), 1543–1570. https://doi.org/10.1081/JA-100106963
17.
GubaE. G.LincolnY. S. (1994). Competing paradigms in qualitative research. In DenzinN. K.LincolnY. S. (Eds.), Handbook of qualitative research (pp. 105–117). SAGE.
18.
HawkinsB. W.ArmstrongH. L.KesselringS.RichA. J.CuiZ.SeredaP.RothE. A. (2019). Substance use as a mechanism for social inclusion among gay, bisexual, and other men who have sex with men in Vancouver, Canada. Substance Use & Misuse, 54(12), 1945–1955. https://doi.org/10.1080/10826084.2019.1621901
19.
HenkelD. (2011). Unemployment and substance use: A review of the literature (1990-2010). Current Drug Abuse Reviews, 4(1), 4–27.
20.
HoughM.NatarajanM. (2000). Introduction: Illegal drug markets, research and policy. Crime Prevention Studies, 11, 1–17.
21.
HserY.-I.LongshoreD.AnglinM. D. (2007). The Life Course Perspective on Drug Use: A conceptual framework for understanding drug use trajectories. Evaluation Review, 31(6), 515–547. https://doi.org/10.1177/0193841X07307316
22.
IvsinsA., Vancouver Area Network of Drug Users, BenoitC.KobayashiK.BoydS. (2019). From risky places to safe spaces: Re-assembling spaces and places in Vancouver’s Downtown Eastside. Health & Place, 59, 102164. https://doi.org/10.1016/j.healthplace.2019.102164
23.
JenkinsV.FarewellV.FarewellD.DarmaninJ.WagstaffJ.LangridgeC.FallowfieldL. (2013). Drivers and barriers to patient participation in RCTs. British Journal of Cancer, 108(7), 1402–1407. https://doi.org/10.1038/bjc.2013.113
24.
KirstM. J. (2009). Social capital and beyond: A qualitative analysis of social contextual and structural influences on drug-use related health behaviors. Journal of Drug Issues, 39(3), 653–676.
25.
KnightR.FastD.DeBeckK.ShovellerJ.SmallW. (2017). “Getting out of downtown”: A longitudinal study of how street-entrenched youth attempt to exit an inner city drug scene. BMC Public Health, 17(1), 1–11. https://doi.org/10.1186/s12889-017-4313-9
26.
KorthuisP. T.LumP. J.Vergara-RodriguezP.AhamadK.WoodE.KunkelL. E.McCartyD. (2017). Feasibility and safety of extended-release naltrexone treatment of opioid and alcohol use disorder in HIV clinics: A pilot/feasibility randomized trial. Addiction, 112(6), 1036–1044. https://doi.org/10.1111/add.13753
27.
KuleszaM.MatsudaM.RamirezJ. J.WentzA. J.TeachmanB. A.LindgrenK. P. (2016). Towards greater understanding of addiction stigma: Intersectionality with race/ethnicity and gender. Drug and Alcohol Dependence, 169(2016), 85–91. https://doi.org/10.1016/j.drugalcdep.2016.10.020
28.
LavalleyJ.KastorS.TourangeauM.GoodmanA.KerrT. (2020). You just have to have other models, our DNA is different: The experiences of indigenous people who use illicit drugs and/or alcohol accessing substance use treatment. Harm Reduction Journal, 17(1), 1–10. https://doi.org/10.1186/s12954-020-00366-3
29.
LeeS. B.ZakA.IversenM. D.PollettaV. L.ShadickN. A.SolomonD. H. (2016). Participation in clinical research registries: A focus group study examining views from patients with arthritis and other chronic illnesses. Arthritis Care and Research, 68(7), 974–980. https://doi.org/10.1002/acr.22767
LiuS.BlomleyN. (2013). Making news and making space: Framing Vancouver’s Downtown Eastside. The Canadian Geographer / Le Géographe Canadien, 57(2), 119–132. https://doi.org/10.1111/j.1541-0064.2012.00453.x
32.
LowtonK. (2005). Trials and tribulations: Understanding motivations for clinical research participation amongst adults with cystic fibrosis. Social Science & Medicine, 61(8), 1854–1865. https://doi.org/10.1016/j.socscimed.2005.03.039
33.
MannellJ.DavisK. (2019). Evaluating complex health interventions with randomized controlled trials: How do we improve the use of qualitative methods?Qualitative Health Research, 29(5), 623–631. https://doi.org/10.1177/1049732319831032
34.
MarshallS. G. (2015). Canadian drug policy and the reproduction of indigenous inequities. International Indigenous Policy Journal, 6(1). https://doi.org/10.18584/iipj.2015.6.1.7
35.
MilesM. B.HubermanA. M. (1994). Making good sense: Drawing and verifying conclusions. In MilesM. B.HubermanA. M. (Eds.), Qualitative data analysis (2nd ed., pp. 245–287). SAGE.
36.
MillsE.CooperC.GuyattG.GilchristA.RachlisB.SulwayC.WilsonK. (2004). Barriers to participating in an HIV vaccine trial: A systematic review. AIDS (London, England), 18, 2235–2242. https://doi.org/00002030-200411190-00003
37.
NealeJ.TompkinsC. N. E.McDonaldR.StrangJ. (2018). Improving recruitment to pharmacological trials for illicit opioid use: Findings from a qualitative focus group study. Addiction, 113(6), 1066–1076. https://doi.org/10.1111/add.14163
38.
PanebiancoD.GallupeO.CarringtonP. J.ColozziI. (2016). Personal support networks, social capital, and risk of relapse among individuals treated for substance use issues. International Journal of Drug Policy, 27, 146–153. https://doi.org/10.1016/j.drugpo.2015.09.009
39.
PaquetteC. E.SyvertsenJ. L.PolliniR. A. (2018). Stigma at every turn: Health services experiences among people who inject drugs. International Journal of Drug Policy, 57, 104–110. https://doi.org/10.1016/j.drugpo.2018.04.004
40.
ParkJ. N.WhiteB.BatesA.EnriquezJ.LiaoL.MaherL. (2012). Motivators and barriers influencing willingness to participate in candidate HCV vaccine trials: Perspectives of people who inject drugs. Drug and Alcohol Dependence, 123(1–3), 35–40. https://doi.org/10.1016/j.drugalcdep.2011.10.009
41.
PettersenH.LandheimA.SkeieI.BiongS.BrodahlM.OuteJ.DavidsonL. (2019). How social relationships influence substance use disorder recovery: A collaborative narrative study. Substance Abuse: Research and Treatment, 13, 1–8. https://doi.org/10.1177/1178221819833379
42.
PortesA. (1998). Social capital: Its origins and applications in modern sociology. Annual Review of Sociology, 24(1), 1–24.
43.
RhodesB. E.GottfredsonN. C.HillL. M. (2018). Desistance and treatment seeking among women with substance use disorders. Qualitative Health Research, 28(8), 1330–1341. https://doi.org/10.1177/1049732318767637
44.
RichardsonL.SmallW.KerrT. (2016). Pathways linking drug use and labour market trajectories: The role of catastrophic events. Sociology of Health and Illness, 38(1), 137–152. https://doi.org/10.1111/1467-9566.12344
45.
RichardsonL.WoodE.KerrT. (2013). The impact of social, structural and physical environmental factors on transitions into employment among people who inject drugs. Social Science & Medicine, 76(1), 126–133. https://doi.org/10.1016/j.socscimed.2012.10.015
SampsonR. J.LaubJ. H. (2005). A life-course view of the development of crime. Annals of the American Academy of Political and Social Science, 602, 12–45. https://doi.org/10.1177/0002716205280075
49.
SavageM. (2009). Contemporary sociology and the challenge of descriptive assemblage. European Journal of Social Theory, 12(1), 155–174. https://doi.org/10.1177/1368431008099650
50.
SeidenfeldJ.HorstmannE.EmanualE.GradyC. (2008). Participants in Phase 1 Oncology Research Trials: Are they vulnerable?Archives of Internal Medicine, 168(1), 16–20.
51.
ShannonK.IshidaT.LaiC.TyndallM. W. (2006). The impact of unregulated single room occupancy hotels on the health status of illicit drug users in Vancouver. International Journal of Drug Policy, 17(2), 107–114. https://doi.org/10.1016/j.drugpo.2005.09.002
52.
SibleyA. L.SchalkoffC. A.RichardE. L.PiscalkoH. M.BrookD. L.LancasterK. E.GoV. F. (2020). “I was raised in addiction”: Constructions of the self and the other in discourses of addiction and recovery. Qualitative Health Research, 30, 2278–2290. https://doi.org/10.1177/1049732320948829
TangmunkongvorakulA.ChariyalertsakS.AmicoK. R.SaokhieoP.WannalakV.SangangamsakunT.GrantR. (2013). Facilitators and barriers to medication adherence in an HIV prevention study among men who have sex with men in the iPrEx study in Chiang Mai, Thailand. AIDS Care, 25(8), 961–967. https://doi.org/10.1080/09540121.2012.748871
55.
TeruyaC.HserY.-I. (2010). Turning points in the life course: Current findings and future directions in drug use research. Current Drug Abuse Reviews, 3(3), 189–195. https://doi.org/10.2174/1874473711003030189
56.
TimmermansS.McKayT. (2009). Clinical trials as treatment option: Bioethics and health care disparities in substance dependency. Social Science and Medicine, 69(12), 1784–1790. https://doi.org/10.1016/j.socscimed.2009.09.019
57.
TompkinsC. N. E.NealeJ.MarsdenJ.StrangJ. (2019). Factors influencing recruitment to a randomised placebo-controlled trial of oral naltrexone and extended release implant naltrexone: Qualitative study. Journal of Substance Abuse Treatment, 99, 52–60. https://doi.org/10.1016/j.jsat.2019.01.012
58.
TownsendA.CoxS. M. (2013). Accessing health services through the back door: A qualitative interview study investigating reasons why people participate in health research in Canada. BMC Medical Ethics, 14(1), 40. https://doi.org/10.1186/1472-6939-14-40
59.
UmbersonD.Karas MontezJ. (2010). Social relationships and health: A flashpoint for health policy. Journal of Health and Social Behavior, 51(1 Suppl.), S54–S66. https://doi.org/10.1177/0022146510383501
60.
Villalonga-OlivesE.KawachiI. (2017). The dark side of social capital: A systematic review of the negative health effects of social capital. Social Science and Medicine, 194, 105–127. https://doi.org/10.1016/j.socscimed.2017.10.020
61.
von HippelC.BrenerL.HorwitzR. (2018). Implicit and explicit internalized stigma: Relationship with risky behaviors, psychosocial functioning and healthcare access among people who inject drugs. Addictive Behaviors, 76, 305–311. https://doi.org/10.1016/j.addbeh.2017.08.036
62.
WalterJ. K.DavisM. M. (2016). Who’s willing? Characteristics associated with willingness to participate in clinical research. IRB: Ethics & Human Research, 38, 15–20.
63.
WittmerJ.ParizeauK. (2016). Informal recyclers’ geographies of surviving neoliberal urbanism in Vancouver, BC. Applied Geography, 66, 92–99. https://doi.org/10.1016/j.apgeog.2015.10.006
64.
YoungA. M.StephensD. B.KhaleelH. A.HavensJ. R. (2015). Hepatitis C vaccine clinical trials among people who use drugs: Potential for participation and involvement in recruitment. Contemporary Clinical Trials, 41, 9–16. https://doi.org/10.1016/j.cct.2014.12.015
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
